Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Santen

Showing results (1-10 of 236) with videos related to

Pageof 24
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 1, 1996
Long-term tamoxifen therapy: can an antagonist become an agonist?R J Santen
Journal of Enzyme Inhibition|January 1, 1990
Clinical use of aromatase inhibitors: current data and future perspectivesR J Santen
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1991
Clinical use of aromatase inhibitors in human breast carcinomaR J Santen
Transactions of the American Clinical and Climatological Association|January 1, 1992
Solving the puzzle of hormone-dependent breast cancerR J Santen
Voprosy Onkologii|June 1, 2001
[Potential for using aromatase inhibitors for preventing breast cancer]R J Santen
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Estrogen synthesis inhibitors: from "off the rack" to haute coutureR J Santen
Cancer Treatment Reviews|December 1, 1984
Aminoglutethimide as an aromatase inhibitor in the treatment of cancerR J Santen
Cancer Surveys|January 1, 1986
Determinants of tissue oestradiol levels in human breast cancerR J Santen
Breast Cancer Research and Treatment|January 1, 1986
Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectivesR J Santen
The Journal of Clinical Endocrinology and Metabolism|December 15, 2010
Clinical review: Effect of endocrine therapies on bone in breast cancer patientsR J Santen
Pageof 24

Showing results (1-10 of 236) with videos related to

Sort By:
Pageof 24
The Journal of Clinical Endocrinology and Metabolism|June 1, 1996
Long-term tamoxifen therapy: can an antagonist become an agonist?R J Santen
Journal of Enzyme Inhibition|January 1, 1990
Clinical use of aromatase inhibitors: current data and future perspectivesR J Santen
The Journal of Steroid Biochemistry and Molecular Biology|January 1, 1991
Clinical use of aromatase inhibitors in human breast carcinomaR J Santen
Transactions of the American Clinical and Climatological Association|January 1, 1992
Solving the puzzle of hormone-dependent breast cancerR J Santen
Voprosy Onkologii|June 1, 2001
[Potential for using aromatase inhibitors for preventing breast cancer]R J Santen
The Journal of Clinical Endocrinology and Metabolism|August 1, 1993
Estrogen synthesis inhibitors: from "off the rack" to haute coutureR J Santen
Cancer Treatment Reviews|December 1, 1984
Aminoglutethimide as an aromatase inhibitor in the treatment of cancerR J Santen
Cancer Surveys|January 1, 1986
Determinants of tissue oestradiol levels in human breast cancerR J Santen
Breast Cancer Research and Treatment|January 1, 1986
Aromatase inhibitors for treatment of breast cancer: current concepts and new perspectivesR J Santen
The Journal of Clinical Endocrinology and Metabolism|December 15, 2010
Clinical review: Effect of endocrine therapies on bone in breast cancer patientsR J Santen
Pageof 24